Search results for the GEO ID: GSE18681  |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM463976 | GPL570 |
|
Patient_9
|
ascites cell sample from non-responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 9 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463976
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463976/suppl/GSM463976.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463977 | GPL570 |
|
Patient_7
|
ascites cell sample from non-responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 7 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463977
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463977/suppl/GSM463977.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463978 | GPL570 |
|
Patient_1
|
ascites cell sample from responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 1 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463978
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463978/suppl/GSM463978.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463979 | GPL570 |
|
Patient_3
|
ascites cell sample from responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 3 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463979
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463979/suppl/GSM463979.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463980 | GPL570 |
|
Patient_4
|
ascites cell sample from responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 4 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463980
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463980/suppl/GSM463980.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463981 | GPL570 |
|
Patient_2
|
ascites cell sample from responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 2 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463981
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463981/suppl/GSM463981.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463982 | GPL570 |
|
Patient_5
|
ascites cell sample from non-responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 5 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463982
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463982/suppl/GSM463982.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463983 | GPL570 |
|
Patient_8
|
ascites cell sample from non-responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 8 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463983
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463983/suppl/GSM463983.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
GSM463984 | GPL570 |
|
Patient_6
|
ascites cell sample from non-responsive patient to infliximab
|
tissue: cells from primary ovarian cancer were obtained from fresh ascites samples
|
ascites cell sample from patient no. 6 treated with therapeutic anti-human TNFα antibody infliximab
|
| Sample_geo_accession | GSM463984
| | Sample_status | Public on Dec 31 2009
| | Sample_submission_date | Oct 21 2009
| | Sample_last_update_date | Oct 21 2009
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | no treatment
| | Sample_growth_protocol_ch1 | Cell pellets from primary ovarian cancer were obtained from fresh ascites samples.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed and purified further with the Rneasy kit (Qiagen) according to the manufacturers instructions
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)
| | Sample_hyb_protocol | Following fragmentation, 10ug of cRNA were hybridised for 16 hr at 45C on GeneChip human U133plus2.0 expression array. Genechips were washed and stained in the Affymetrix Fludics Station 450.
| | Sample_scan_protocol | Genechips were scanned using the Affymetrix Genechip Scanner 3000G
| | Sample_data_processing | Data was analysed using Biocondutor 1.95 running on R2.6.0. Probe set expression measures were calcualted using the Affy package Robust Multichip Average default method.
| | Sample_platform_id | GPL570
| | Sample_contact_name | Hagen,,Kulbe
| | Sample_contact_email | h.kulbe@qmul.ac.uk
| | Sample_contact_department | Centre for Cancer and Inflammation
| | Sample_contact_institute | Institute of Cancer and the CR-UK Clinical Centre, Barts and The London School of Medicine and Dentistry
| | Sample_contact_address | Charterhouse Square
| | Sample_contact_city | London
| | Sample_contact_zip/postal_code | EC1M 6BQ
| | Sample_contact_country | United Kingdom
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463984/suppl/GSM463984.CEL.gz
| | Sample_series_id | GSE18681
| | Sample_data_row_count | 54675
| | |
|
| |
| |
Make groups for comparisons |
(2 groups will be compared at a time) |
|
| Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|
